Vimarsana
Biggest News Aggregation in the World

Eithne Costello News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eithne Costello. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eithne Costello Today - Breaking & Trending Today

Detecting pancreatic cancer earlier with the help of gifts in Wills - Vimarsana News

Detecting pancreatic cancer earlier with the help of gifts in Wills

Thanks to research, more people than ever are surviving their cancer. In the 1970s, just 1 in 4 people in the UK survived cancer for 10 years or…

Detecting pancreatic cancer earlier with the help of gifts in Wills - Vimarsana News

Detecting pancreatic cancer earlier with the help of gifts in Wills

Thanks to research, more people than ever are surviving their cancer. In the 1970s, just 1 in 4 people in the UK survived cancer for 10 years or…

Tiny Worms Sniff Out Early-Stage Pancreatic Cancer - Vimarsana News

Tiny Worms Sniff Out Early-Stage Pancreatic Cancer

Early data indicate nematodes could help oncologists identify these deadly cancers much sooner.

Britain's Hidden Killer: Tonight - Vimarsana News

Britain's Hidden Killer: Tonight

'Britain's Hidden Killer' is on ITV this Friday 15th October at 8pm. | ITV National News

Source: itv.com
University of Liverpool signs option agreement with BARD1 for type 3C diabetes test - Vimarsana News

University of Liverpool signs option agreement with BARD1 for type 3C diabetes test

University of Liverpool signs option agreement with BARD1 for type 3C diabetes test The University of Liverpool has signed a two year option agreement with the Australian diagnostics company, BARD1 Life Sciences Ltd, for a type 3c diabetes (T3cDM) blood test. The test uses patented technology developed by researchers in the University of Liverpool's Institute of Systems, Molecular and Integrative Biology. There are around 22.9 million new cases of new-onset diabetes diagnosed around the globe. T3cDM diabetes occurs in around 10 per cent of all new-onset diabetes cases. Currently, no test exis...